SCHEMBL22345206

SCHEMBL22345206

CC(NC1C(=O)Nc2ccccc21)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 7/20 0.49
TDO2 P48775 4/20 0.49
MAPT P10636 7/20 0.44
KDM4E B2RXH2 5/20 0.44
TDP1 Q9NUW8 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NLRP3 Q96P20 1/20 0.40
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HPGDS O60760 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8226202 0.83 MAPT (0.43) IDO1TDO2MAPTKDM4ETDP1
SCHEMBL19000599 0.76 IDO1 (0.51) IDO1TDO2MAPTKDM4ETDP1
SCHEMBL31073452 0.75 MAPT (0.61) IDO1TDO2MAPTKDM4ETDP1
SCHEMBL721134 0.74 KMT2A (0.59) MAPTMEN1KMT2APOLBGAA
SCHEMBL8195596 0.74 KMT2A (0.59) MAPTMEN1KMT2APOLBGAA
SCHEMBL24754644 0.74 IDO1 (0.46) IDO1TDO2MAPTKDM4ETDP1
SCHEMBL28859743 0.74 IDO1 (0.46) IDO1TDO2MAPTKDM4ETDP1
SCHEMBL1491212 0.74 KDM4E (0.47) IDO1TDO2MAPTKDM4ETDP1
Hydrochloric Acid SCHEMBL1491278 0.73 KDM4E (0.46) IDO1TDO2MAPTKDM4ETDP1
SCHEMBL27693694 0.73 HPGDS (0.54) IDO1TDO2MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3923905-A1 LIQUID PHARMACEUTICAL FORMULATIONS OF PTH CONJUGATES Ascendis Pharma Bone Diseases A/S (DK) 2021-12-22 EP disclosed
CN-113423383-A Liquid pharmaceutical formulations of PTH conjugates 阿森迪斯药物骨疾病股份有限公司 2021-09-21 CN disclosed
WO-2020165087-A1 LIQUID PHARMACEUTICAL FORMULATIONS OF PTH CONJUGATES ASCENDIS PHARMA BONE DISEASES A/S (DK) 2020-08-20 WO disclosed